Zoetis Inc. (NYSE: ZTS) today announced the commercial launch of Portela ® (relfovetmab) in Canada and the European Union (EU) member states. Portela is the first long-acting anti-nerve growth factor ...
Morning Overview on MSN
The FDA cleared a once-a-week Alzheimer’s shot that patients can give themselves at home
People living with early Alzheimer’s disease can now begin treatment with Leqembi without setting foot in an infusion center.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results